Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04641234
What this trial is testing

A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD).

Who this might be right for
Neovascular Age-related Macular Degeneration
Bayer 330
Testing effectiveness (Phase 2)Ended earlyNCT01577381
What this trial is testing

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Maculopathy
Pfizer 10
Not applicableLooking for participantsNCT05465252
What this trial is testing

Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression

Who this might be right for
Age-Related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 24
Early research (Phase 1)Looking for participantsNCT03178149
What this trial is testing

The Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 42
Post-approval studies (Phase 4)Study completedNCT04474821
What this trial is testing

HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults

Who this might be right for
Human Papillomavirus InfectionHuman Papillomavirus-Related Carcinoma
Mayo Clinic 100
Not applicableNot Yet RecruitingNCT05247814
What this trial is testing

Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients

Who this might be right for
PolypharmacyPharmacogeneticsPharmacogenomic Testing+1 more
RWTH Aachen University 2,000
Not applicableStudy completedNCT02569892
What this trial is testing

Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration

Who this might be right for
Macular DegenerationRetinal Drusen
Stanford University 19
Testing effectiveness (Phase 2)Study completedNCT04331730
What this trial is testing

Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Alkahest, Inc. 107
Testing effectiveness (Phase 2)Study completedNCT06454071
What this trial is testing

Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients

Who this might be right for
Cancer of ColonInterleukinsAged
Soonchunhyang University Hospital 75
Not applicableStudy completedNCT07428798
What this trial is testing

Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyDry Age Related Macular Degeneration
Marmara University Pendik Training and Research Hospital 14
Not applicableUnknownNCT02988895
What this trial is testing

Episcleral Brachytherapy for the Treatment of Wet AMD

Who this might be right for
Macular Degeneration, Choroidal Neovascularization
Salutaris Medical Devices, Inc. 11
Testing effectiveness (Phase 2)UnknownNCT02755428
What this trial is testing

Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases

Who this might be right for
Dry Age-related Macular Degeneration
Chinese Academy of Sciences 10
Not applicableStudy completedNCT04132401
What this trial is testing

AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care

Who this might be right for
Diabetic RetinopathyGlaucomaAge-Related Macular Degeneration+2 more
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 902
Not applicableNot Yet RecruitingNCT07473830
What this trial is testing

PANDORA: Evaluation of Platelet-rich Plasma in Non-tumoural Odour Disorders: a Descriptive Pilot Study.

Who this might be right for
Olfactory DysfunctionPost-traumatic Olfactory DysfunctionAge-related Degenerative Olfactory Dysfunction
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)Study completedNCT02914639
What this trial is testing

Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
OcuTerra Therapeutics, Inc. 44
Not applicableStudy completedNCT01243645
What this trial is testing

MP-1 Biofeedback: Pattern Stimulus Versus Audio-feedback in AMD

Who this might be right for
Age Related Macular Degeneration
University of Roma La Sapienza
Not applicableStudy completedNCT03225131
What this trial is testing

Dark Adaptation in Participants With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 57
Early research (Phase 1)Study completedNCT01051700
What this trial is testing

A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans

Who this might be right for
Macular Degeneration
GlaxoSmithKline 72
Not applicableUnknownNCT03978650
What this trial is testing

Risk Factors for Falls and Fall-related Injuries Associated With Mild Neurocognitive Disorders

Who this might be right for
Old AgeFall InjuryNeurocognitive Disorders
Jewish General Hospital 12,000
Early research (Phase 1)Looking for participantsNCT07662096
What this trial is testing

A First-In-Human Study of ARO-033 in Adult Participants

Who this might be right for
Age-related Macular Degeneration
Arrowhead Pharmaceuticals 84
Next Page